ABSTRACT The effect of beta-adrenoceptor antagonists on the respiratory response to carbon dioxide rebreathing was studied in eight normal subjects. Propranolol, atenolol, metoprolol, and placebo were given in random, double-blind fashion. Subjects were studied before each treatment period, after one dose, and after eight days of treatment with each drug. A 
Beta-adrenergic antagonists are used extensively in clinical practice but can produce airway narrowing in susceptible patients, particularly those with asthma.' The use of relatively cardioselective beta blockers may lessen the risk of bronchoconstriction but as some patients with airflow obstruction also have disordered ventilatory control,2 it must be established whether the respiratory effects of beta-adrenergic blockade extend beyond changes in pulmonary mechanics.
Mustchin et al3 observed that a single oral dose of propranolol markedly reduced the respiratory response to carbon dioxide rebreathing in normal volunteers, suggesting an effect on central control. Since a single dose of a non-cardioselective betablocker is unlikely to be given to patients at risk, we attempted to simulate the clinical situation by observing the effects of both acute and chronic beta blockade on ventilatory control. We used two widely prescribed cardioselective betablockers, atenolol and metoprolol, and compared them with a non-cardioselective drug, propranolol, in normal subjects. Metoprolol The order in which the courses were given was randomised for each subject, identical tablets of propranolol, atenolol, and placebo were used with a non-identical standard commercial preparation of metoprolol (Betaloc, Astra). The study was designed to be double-blind.
Subjects were made familiar with the rebreathing procedure before entering the formal study. They were studied at the same time of day on the first and last day of each course. No coffee, tea, or nicotine was allowed on study days and tablets were taken on an empty stomach.
On the first study day subjects rested supine for 15 minutes before performing a rebreathing run followed by spirometry and an exercise test. The first dose of the tablet was given and two hours later after a further period of rest the three tests were repeated in the same sequence. They then took the tablets for seven days and on the eighth day returned to the laboratory to repeat the three tests two hours after that day's dose. A two-week wash-out period was allowed between courses.
The first rebreathing run in each course before any treatment acted as control and was compared with the CO2 responses after acute and chronic drug administration. The within-subject day-to-day variability in the response to CO2 rebreathing was assessed as the coefficient of variation of the slopes and intercepts of each subject's four control runs. For the a19 who studied metoprolol and propranolol. This is the first report of the effects of chronic dosage and we believe it to be relevant to clinical practice since it approximates to the way in which the drugs are actually given, and because the effects of chronic treatment are not necessarily the same as those of a single dose. For instance, pretreatment with atenolol may enhance its central nervous system uptake,4 while the effects of the pharmacologically active metabolite of propranolol, 4-hydroxy-propranolol may be important after a single dose but are not seen when the drug is given for more than five days.'0
We were unable to repeat the observations of Mustchin et al3 or support their conclusions that propranolol is a respiratory depressant. We are unable to explain this discrepancy although Mustchin" has himself emphasised the problems of using CO2 rebreathing as a pharmacological tool, predominantly because of its poor within-subject reproducibility. Some of the factors contributing to this variability, such as the recent intake of coffee or the performance of the tests at different times of the day, can be controlled. Despite attention to such details we still found large spontaneous within-subject variation in CO2 sensitivity between control runs, as illustrated by the large coefficients of variation ( 
